Related Experiment Video
Updated: Jun 6, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
218
[Breast Cancer With Synchronous Metastases At The Gabriel Toure University Hospital: Frequency And Prognosis]
B Diawara1, I Téguété1, F K Tounkara2
1Centre Hospitalier Universitaire Gabriel Touré, service de gynécologie - obstétrique, Bamako, Mali.
Le Mali Medical
|November 25, 2024
Summary
Synchronous metastatic breast cancer is common in Mali, with a high mortality rate. Lung metastasis significantly increases the risk of death in breast cancer patients.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Context:
- Breast cancer metastasis is a significant cause of mortality globally.
- Metastatic breast cancer (MBC) presents unique challenges in low-resource settings.
- Understanding MBC epidemiology in Sub-Saharan Africa is crucial for targeted interventions.
Purpose:
- To estimate the frequency of synchronous metastatic breast cancer (SMBC).
- To determine the overall survival rate for SMBC patients.
- To identify factors associated with mortality in Malian women with MBC.
Summary:
- A retrospective cohort study analyzed 231 breast cancer cases from 2018-2021.
- 60 cases (26%) were diagnosed with synchronous metastatic breast cancer.
- Lung metastasis was identified as a significant risk factor for mortality (AHR=4.22).
Impact:
- The study highlights the high burden of SMBC in the Malian population.
- A poor prognosis was observed, with a 2-year survival rate below 20%.
- Findings underscore the urgent need for improved diagnostic and therapeutic strategies for MBC in the region.
